Trial intelligence / Profile preview

PLX3397 in unresectable or metastatic KIT-mutant melanoma

CTR20160448Phase 2Suspended

Sponsor

Plexxikon Inc.

Start

Nov 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1